摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-chloro-11-(1-(methylsulfonyl)piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine

中文名称
——
中文别名
——
英文名称
8-chloro-11-(1-(methylsulfonyl)piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
英文别名
8-Chloro-11-(1-methanesulfonyl-piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine;13-Chloro-2-(1-methylsulfonylpiperidin-4-ylidene)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene
8-chloro-11-(1-(methylsulfonyl)piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine化学式
CAS
——
化学式
C20H21ClN2O2S
mdl
——
分子量
388.918
InChiKey
YDDVSUDVRYZXAY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.2
  • 重原子数:
    26
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    58.6
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    Novel tricyclic aminoacetyl and sulfonamide inhibitors of Ras farnesyl protein transferase
    摘要:
    Novel tricyclic FPT inhibitors with submicromolar FPT activity are described. Greatly enhanced FPT activity is realized with phthaloyl derivatized amino compound 2k, which showed FPT inhibitory activity of IC50 = 0.66 mu M. Sulfonamides 5g and 50 were also found to be potent FPT inhibitor. SAR resulting from a variety of tricyclic amino acids and sulfonamide derivatives is discussed. Copyright (C) 1996 Elsevier Science Ltd
    DOI:
    10.1016/s0960-894x(96)00558-6
点击查看最新优质反应信息

文献信息

  • Synthesis of Isomeric 3-Piperidinyl and 3-Pyrrolidinyl Benzo[5,6]cyclohepta[1,2-b]pyridines: Sulfonamido Derivatives as Inhibitors of Ras Prenylation
    作者:Joseph Kelly、Ronald Wolin、Michael Connolly、Adriano Afonso、Linda James、Paul Kirshmeier、W.Robert Bishop、Andrew T. McPhail
    DOI:10.1016/s0968-0896(98)00026-1
    日期:1998.6
    Blocking farnesylation of oncogenic Ras proteins is a mechanism based therapeutic approach that is of current interest for the development of antitumor agents to treat ras associated tumors. As part of a SAR study on the lead farnesyl protein transferase (FPT) inhibitor I, we report here the synthesis of novel geometric isomers II and III and the FPT inhibition activity of their N-acyl and N-sulfonamido
    阻断致癌性Ras蛋白的法尼基化是一种基于机制的治疗方法,目前对于开发治疗ras相关肿瘤的抗肿瘤药物具有重要意义。作为对法呢基铅蛋白转移酶(FPT)抑制剂I的SAR研究的一部分,我们在这里报告了新型几何异构体II和III的合成及其N-酰基和N-磺酰胺基衍生物15-65的FPT抑制活性。N-酰基衍生物的活性显着低于铅抑制剂I,从而表明I中N-酰基的空间位置对于化合物与FPT的结合至关重要。与I相反,N-磺酰胺基-II系列是非巯基非肽类化合物的新型先导,它们是FPT / GGPT双重抑制剂。根据最近有关N-和K-Ras异戊烯化的报道,
  • [EN] TRICYCLIC COMPOUND AND PHARMACEUTICAL USE THEREOF<br/>[FR] COMPOSÉ TRICYCLIQUE ET SON UTILISATION PHARMACEUTIQUE<br/>[KO] 삼환식 화합물 및 이의 약학적 용도
    申请人:JD BIOSCIENCE INC
    公开号:WO2021086133A1
    公开(公告)日:2021-05-06
    본 발명의 화학식 1로 표시되는 삼환식 유도체 또는 이의 약학적으로 허용가능한 염인 화합물은 세로토닌 활성을 저해하는 효과가 우수하므로, 이를 포함하는 약학적 조성물은 세로토닌 활성화와 관련된 대사성 질환 등의 예방 또는 치료에 유용하게 사용될 수 있다.
  • Novel tricyclic aminoacetyl and sulfonamide inhibitors of Ras farnesyl protein transferase
    作者:F.George Njoroge、Bancha Vibulbhan、Carmen S. Alvarez、W.Robert Bishop、Joanne Petrin、Ronald J. Doll、V. Girijavallabhan、Ashit K. Ganguly
    DOI:10.1016/s0960-894x(96)00558-6
    日期:1996.12
    Novel tricyclic FPT inhibitors with submicromolar FPT activity are described. Greatly enhanced FPT activity is realized with phthaloyl derivatized amino compound 2k, which showed FPT inhibitory activity of IC50 = 0.66 mu M. Sulfonamides 5g and 50 were also found to be potent FPT inhibitor. SAR resulting from a variety of tricyclic amino acids and sulfonamide derivatives is discussed. Copyright (C) 1996 Elsevier Science Ltd
查看更多

同类化合物

马来酸阿扎他啶 脱羧氯雷他定杂质B 盐酸氯雷他定 盐酸氯雷他定 洛那法尼 氯雷他定脱氯杂质 氯雷他定环氧化物 氯雷他定杂质I 氯雷他定杂质F 氯雷他定杂质C 氯雷他定杂质50 氯雷他定杂质29 氯雷他定杂质26 氯雷他定杂质17 氯雷他定杂质14 氯雷他定杂质1 氯雷他定杂质 氯雷他定8-溴代杂质 氯雷他定 托吡林 富马酸卢帕他定 地氯雷他定杂质14 地氯雷他定杂质1 地氯雷他定异构体 地氯雷他定-D4 地氯雷他定 去氯雷他定-N-羟基哌啶 卢帕他定杂质C 卢帕他定杂质B 卢帕他定杂质2 卢帕他定杂质 卢帕他定 乙基4-[8-氯-4-(羟基甲基)-5,6-二氢-11H-苯并[5,6]环庚并[1,2-b]吡啶-11-亚基]-1-哌啶羧酸酯 乙基4-(8-氯-3-羟基-5,6-二氢-11H-苯并[5,6]环庚并[1,2-b]吡啶-11-亚基)-1-哌啶羧酸酯 乙基4-(8-氯-3-甲氧基-5,6-二氢-11H-苯并[5,6]环庚并[1,2-b]吡啶-11-亚基)-1-哌啶羧酸酯 乙基4-(8-氯-1-氧代-5,6-二氢-11H-苯并[5,6]环庚并[1,2-b]吡啶-11-亚基)-1-哌啶羧酸酯 [4-(8-氯-5,6-二氢-11H-苯并[5,6]环庚[1,2-b]吡啶基-11亚烷基)-1-哌啶基](1H-1,2,4-三唑-1-基)甲酮 N-甲酰基地氯雷他定 N-亚硝基地氯雷他定 N-乙酰基地氯雷他定 D3-3-氧代丁酸甲酯 8-脱氯-9-氯氯雷他定 8-脱氯-9-氯地氯雷他定 8-脱氯-9-氯-N-甲基地氯雷他定 8-氯-6,11-二氢-11-(4-哌啶基亚基)-5H-苯并[5,6]环庚三烯并[1,2-B]吡啶-2,3,4,5,5-D5 8-氯-6,11-二氢-11-(1-甲基-4-哌啶基)-5H-苯并[5,6]环庚烷[1,2-b]吡啶-11-醇 8-氯-6,11-二氢-11-(1-甲基-4-哌啶叉)-5H-苯并[5,6]环庚烷[1,2-b]吡啶 8-氯-5,6-二氢-11H-苯并[5,6]环庚烷并[1,2-b]吡啶-11-酮 8-氯-5,6-二氢-11H-苯并[5,6]环庚并[1,2-b]吡啶-11-酮 1-氧化物 8-氯-3-甲氧基-5,6-二氢-11H-苯并[5,6]环庚并[1,2-b]吡啶-11-酮